The Medicare Payment Advisory Commission (MedPAC) held their second public meeting of the current term on October 5-6, 2017. While no recommendations were presented, the topics discussed by the Commissioners indicate areas where MedPAC may offer recommendations during this term. The first session of the meeting looked at possible next steps for the Merit-based Incentive […]
Read MoreOn September 7-8, 2017, the Medicare Payment Advisory Commission (MedPAC) had the first meeting of their new term. The meeting contained sessions that mostly focused on providing Commissioners with information about various Medicare-related topics that could be areas for further exploration. No policy recommendations were discussed or voted on. In addition, the meeting introduced the Commission’s […]
Read MoreOn April 6-7, 2017, the Medicare Payment Advisory Commission (MedPAC) held their final public meeting of this term. The Commissioners finished out this term by voting on draft recommendations presented at previous meetings and discussing a wide range of topics, including Medicare Part B drug payment, a unified payment system for post-acute care, and payment […]
Read MoreAt today’s meeting, the Medicare Payment Advisory Commission (MedPAC) began their consideration of challenges facing the Medicare Part D prescription drug benefit, building up to a slate of recommendations to be included in their report to Congress later this year. Last year, the Commission approved several changes aimed at shifting more risk away from the […]
Read MoreOn Thursday, November 4th, the Medicare Payment Advisory Commission (MedPAC) hosted the next public meeting of their current term. The topics of the meeting varied but heavily featured provider-related topics in Medicare. The meeting agenda and presentations can be found here. Provider Consolidation: The Role of Medicare Policy The first topic at the meeting was […]
Read MoreThe Medicare Payment Advisory Commission (MedPAC) held the second meeting of their new term on October 6, 2016 and October 7, 2016. The Commission covered a number of topics, but much attention was given Medicare Accountable Care Organizations, Medicare Part B drug payment policy, and biosimilars in Medicare Part D. At the meeting, commissioners were […]
Read MoreThe Medicare Payment Advisory Commission’s (MedPAC’s) initial public meeting of the new term, which was held on September 8, may telegraph what the Commission may make recommendations to Congress on in the upcoming year. The meeting featured presentations and discussions on a wide range of issues, including a context for Medicare payment policy, an overview […]
Read MoreAt their meeting on April 7, 2016, MedPAC voted unanimously to approve a package of recommendations that could potentially save the Part D program $10 billion over 5 years. The recommendations would combine shifting more risk to Part D plan sponsors, especially for high-cost drugs, but would also grant plan sponsors more flexibility in implementing […]
Read More